Calcineurin and Electrical Remodeling in Pathologic Cardiac Hypertrophy

Trends in Cardiovascular Medicine

Volumn 20, Issue 5, 2010, Pages 148-153

  Liu, Hui Bin ^a   Yang, Bao Feng ^a   Dong, De Li ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Bio pharmaceutical Key Laboratory of Heilongjiang Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CHLORIDE CHANNEL;

HEART ELECTROPHYSIOLOGY; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

CALCINEURIN; CARDIOMEGALY; ELECTROPHYSIOLOGICAL PHENOMENA; HUMANS;

EID: 79960088052     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2010.12.003     Document Type: Review

References (48)

1. Bernardo B.C., Weeks K.L., Pretorius L., et al. Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther 2010, 128:191-227.
2. Bierhuizen M.F., Boulaksil M., Van Stuijvenberg L., et al. In calcineurin-induced cardiac hypertrophy expression of Nav1.5, Cx40 and Cx43 is reduced by different mechanisms. J Mol Cell Cardiol 2008, 45:373-384.
3. Bush E.W., Hood D.B., Papst P.J., et al. Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling. J Biol Chem 2006, 281:33487-33496.
4. Chiang C.S., Huang C.H., Chieng H., et al. The Cav3.2 T-type Ca2+ channel is required for pressure overload-induced cardiac hypertrophy in mice. Circ Res 2009, 104:522-530.
5. Dhalla N.S., Dixon I.M., Rupp H., et al. Experimental congestive heart failure due to myocardial infarction: sarcolemmal receptors and cation transporters. Basic Res Cardiol 86 Suppl 1991, 3:13-23.
6. Dong D., Duan Y., Guo J., et al. Overexpression of calcineurin in mouse causes sudden cardiac death associated with decreased density of K+ channels. Cardiovasc Res 2003, 57:320-332.
7. Dong D.L., Chen C., Huo R., et al. Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy. Hypertension 2010, 55:946-952.
8. Duan D. Phenomics of cardiac chloride channels: the systematic study of chloride channel function in the heart. J Physiol 2009, 587:2163-2177.
9. Gong N., Bodi I., Zobel C., et al. Calcineurin increases cardiac transient outward K+ currents via transcriptional up-regulation of Kv4.2 channel subunits. J Biol Chem 2006, 281:38498-38506.
10. Guo J., Zhan S., Somers J., et al. Decrease in density of INa is in the common final pathway to heart block in murine hearts overexpressing calcineurin. Am J Physiol Heart Circ Physiol 2006, 291:H2669-H2679.
11. Horiba M., Muto T., Ueda N., et al. T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers. Life Sci 2008, 82:554-560.
12. Huang B., Qin D., Deng L., et al. Reexpression of T-type Ca2+ channel gene and current in post-infarction remodeled rat left ventricle. Cardiovasc Res 2000, 46:442-449.
13. Kaab S., Nuss H.B., Chiamvimonvat N., et al. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res 1996, 78:262-273.
14. Kassiri Z., Zobel C., Nguyen T.T., et al. Reduction of Ito causes hypertrophy in neonatal rat ventricular myocytes. Circ Res 2002, 90:578-585.
15. Katanosaka Y., Iwata Y., Kobayashi Y., et al. Calcineurin inhibits Na+/Ca2+ exchange in phenylephrine-treated hypertrophic cardiomyocytes. J Biol Chem 2005, 280:5764-5772.
16. Kinoshita H., Kuwahara K., Nishida M., et al. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart. Circ Res 2010, 106:1849-1860.
17. Kuwahara K., Wang Y., McAnally J., et al. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. J Clin Invest 2006, 116:3114-3126.
18. Lebeche D., Kaprielian R., del Monte F., et al. In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis. Circulation 2004, 110:3435-3443.
19. Lebeche D., Kaprielian R., Hajjar R. Modulation of action potential duration on myocyte hypertrophic pathways. J Mol Cell Cardiol 2006, 40:725-735.
20. Leinwand L.A. Calcineurin inhibition and cardiac hypertrophy: a matter of balance. Proc Natl Acad Sci U S A 2001, 98:2947-2949.
21. Li G.R., Lau C.P., Ducharme A., et al. Transmural action potential and ionic current remodeling in ventricles of failing canine hearts. Am J Physiol Heart Circ Physiol 2002, 283:H1031-H1041.
22. Li G.R., Lau C.P., Leung T.K., et al. Ionic current abnormalities associated with prolonged action potentials in cardiomyocytes from diseased human right ventricles. Heart Rhythm 2004, 1:460-468.
23. Maltsev V.A., Silverman N., Sabbah H.N., et al. Chronic heart failure slows late sodium current in human and canine ventricular myocytes: implications for repolarization variability. Eur J Heart Fail 2007, 9:219-227.
24. Massart P.E., Donckier J., Kyselovic J., et al. Carvedilol and lacidipine prevent cardiac hypertrophy and endothelin-1 gene overexpression after aortic banding. Hypertension 1999, 34:1197-1201.
25. Muth J.N., Bodi I., Lewis W., et al. A Ca2+-dependent transgenic model of cardiac hypertrophy: a role for protein kinase Calpha. Circulation 2001, 103:140-147.
26. Nakayama H., Wilkin B.J., Bodi I., et al. Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart. FASEB J 2006, 20:1660-1670.
27. Ohba T., Watanabe H., Murakami M., et al. Upregulation of TRPC1 in the development of cardiac hypertrophy. J Mol Cell Cardiol 2007, 42:498-507.
28. Perrier E., Perrier R., Richard S., et al. Ca2+ controls functional expression of the cardiac K+ transient outward current via the calcineurin pathway. J Biol Chem 2004, 279:40634-40639.
29. Petrashevskaya N.N., Bodi I., Rubio M., et al. Cardiac function and electrical remodeling of the calcineurin-overexpressed transgenic mouse. Cardiovasc Res 2002, 54:117-132.
30. Pitt G.S., Dun W., Boyden P.A. Remodeled cardiac calcium channels. J Mol Cell Cardiol 2006, 41:373-388.
31. Rossow C.F., Dilly K.W., Yuan C., et al. NFATc3-dependent loss of Ito gradient across the left ventricular wall during chronic beta adrenergic stimulation. J Mol Cell Cardiol 2009, 46:249-256.
32. Sah R., Oudit G.Y., Nguyen T.T., et al. Inhibition of calcineurin and sarcolemmal Ca2+ influx protects cardiac morphology and ventricular function in Kv4.2N transgenic mice. Circulation 2002, 105:1850-1856.
33. Schwinger R.H., Wang J., Frank K., et al. Reduced sodium pump alpha1, alpha3, and beta1-isoform protein levels and Na+,K+-ATPase activity but unchanged Na+-Ca2+ exchanger protein levels in human heart failure. Circulation 1999, 99:2105-2112.
34. Seth M., Zhang Z.S., Mao L., et al. TRPC1 channels are critical for hypertrophic signaling in the heart. Circ Res 2009, 105:1023-1030.
35. Shigekawa M., Katanosaka Y., Wakabayashi S. Regulation of the cardiac Na+/Ca2+ exchanger by calcineurin and protein kinase C. Ann N Y Acad Sci 2007, 1099:53-63.
36. Tandan S., Wang Y., Wang T.T., et al. Physical and functional interaction between calcineurin and the cardiac L-type Ca2+ channel. Circ Res 2009, 105:51-60.
37. Tsuji Y., Opthof T., Yasui K., et al. Ionic mechanisms of acquired QT prolongation and torsades de pointes in rabbits with chronic complete atrioventricular block. Circulation 2002, 106:2012-2018.
38. Valdivia C.R., Chu W.W., Pu J., et al. Increased late sodium current in myocytes from a canine heart failure model and from failing human heart. J Mol Cell Cardiol 2005, 38:475-483.
39. Vindis C., D'Angelo R., Mucher E., et al. Essential role of TRPC1 channels in cardiomyoblasts hypertrophy mediated by 5-HT2A serotonin receptors. Biochem Biophys Res Commun 2009, 391:979-983.
40. Wang Z., Kutschke W., Richardson K.E., et al. Electrical remodeling in pressure-overload cardiac hypertrophy: role of calcineurin. Circulation 2001, 104:1657-1663.
41. Wang Z., Nolan B., Kutschke W., et al. Na+-Ca2+ exchanger remodeling in pressure overload cardiac hypertrophy. J Biol Chem 2001, 276:17706-17711.
42. Wilkins B.J., Dai Y.S., Bueno O.F., et al. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res 2004, 94:110-118.
43. Wu X., Eder P., Chang B., et al. TRPC channels are necessary mediators of pathologic cardiac hypertrophy. Proc Natl Acad Sci U S A 2010, 107:7000-7005.
44. Xiao L., Coutu P., Villeneuve L.R., et al. Mechanisms underlying rate-dependent remodeling of transient outward potassium current in canine ventricular myocytes. Circ Res 2008, 103:733-742.
45. Xiong D., Heyman N.S., Airey J., et al. Cardiac-specific, inducible ClC-3 gene deletion eliminates native volume-sensitive chloride channels and produces myocardial hypertrophy in adult mice. J Mol Cell Cardiol 2009, 48:211-219.
46. Xu X., Rials S.J., Wu Y., et al. Left ventricular hypertrophy decreases slowly but not rapidly activating delayed rectifier potassium currents of epicardial and endocardial myocytes in rabbits. Circulation 2001, 103:1585-1590.
47. Yang K.C., Foeger N.C., Marionneau C., et al. Homeostatic regulation of electrical excitability in physiological cardiac hypertrophy. J Physiol 2010, 588:5015-5032.
48. Zicha S., Maltsev V.A., Nattel S., et al. Post-transcriptional alterations in the expression of cardiac Na+ channel subunits in chronic heart failure. J Mol Cell Cardiol 2004, 37:91-100.